Press release
Inhalers & Nebulizers Market worth $38.63 billion by 2030, growing at a CAGR of 22.55% - Exclusive Report by 360iResearch
Inhalers & Nebulizers Market | 360iResearch
The Global Inhalers & Nebulizers Market to grow from USD 9.30 billion in 2023 to USD 38.63 billion by 2030, at a CAGR of 22.55%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/inhalers-nebulizers?utm_source=openpr&utm_medium=referral&utm_campaign=sample
Inhalers are compact, portable medical devices that deliver medication directly into the lungs. Inhalers come in various forms, including metered-dose inhalers (MDIs), which release a specific amount of medication in aerosol form, and dry powder inhalers (DPIs), which dispense medication in a dry powder form triggered by the patient's inhalation. Nebulizers are electronic devices that transform liquid medication into a fine mist, allowing patients to inhale the substance through a face mask or mouthpiece. Patients with respiratory diseases primarily use inhalers and nebulizers for medication administration. The increase in incidences of respiratory diseases due to pollution and smoking habits and growing awareness about the need for early diagnosis and treatment of respiratory conditions has improved the need for inhalers & nebulizers. However, the high cost of advanced inhaler technologies, the complexity of medication adherence, and patient errors in using inhaler devices correctly limit the penetration of inhalers & nebulizers. Nevertheless, the development of smart inhalers integrated with digital capabilities for monitoring usage patterns and improving compliance and the emergence of customizable options to enhance user experience is expanding the scope of the inhalers & nebulizers market worldwide.
The Americas represents a highly developing and standardized inhalers & nebulizers market due to the high prevalence of respiratory diseases, supportive government approvals, and development of novel product portfolios. Customer purchasing behavior in the Americas is strongly influenced by technological advancements and the presence of major pharmaceutical vendors investing in innovative delivery systems. Asia-Pacific's investment in healthcare infrastructure and local pharmaceutical manufacturing fosters the growth of the inhalers & nebulizers market. A vast population and a rising incidence of respiratory conditions with an increasing trend in the use of generic drugs have expanded the scope of inhalers & nebulizers market in the Asia-Pacific. The European market is sophisticated, with stringent regulations and high penetration of advanced inhaler devices. The focus on patient compliance and ease of use drives the demand for smart and connected inhalers across the EMEA region. Africa is an emerging market with a high burden of respiratory diseases but has limited access to healthcare facilities. The increasing healthcare expenditure and desire for premium healthcare services and products are noticeable among the affluent customer segment across the EMEA region.
Market Segmentation & Coverage:
This research report categorizes the Inhalers & Nebulizers Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Product, market is studied across Inhalers and Nebulizers. The Inhalers is further studied across Dry Powder Inhalers and Metered Dose Inhalers. The Nebulizers is further studied across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer. The Nebulizers commanded largest market share of 60.25% in 2023, followed by Inhalers.
Based on Indication, market is studied across Asthma and COPD. The Asthma commanded largest market share of 53.80% in 2023, followed by COPD.
Based on Distribution Mode, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies commanded largest market share of 42.09% in 2023, followed by Hospital Pharmacies.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 36.00% in 2023, followed by Europe, Middle East & Africa.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/inhalers-nebulizers?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Inhalers & Nebulizers Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Inhalers & Nebulizers Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AMIKO Digital Health, AptarGroup, Inc., Beurer GmbH, Beximco Pharmaceuticals Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Dr Trust by Nureca Ltd., Drive DeVilbiss International, GF Health Products, Inc., GlaxoSmithKline PLC, H&T Presspart, ICONOVO AB, Koninklijke Philips N.V., Merck Group, Mundipharma GmbH, Narang Medical Limited, Novartis AG, Omron Corporation, PARI GmbH, Sensirion AG, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Vectura Group Ltd..
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Inhalers & Nebulizers Market, by Product
7. Inhalers & Nebulizers Market, by Indication
8. Inhalers & Nebulizers Market, by Distribution Mode
9. Americas Inhalers & Nebulizers Market
10. Asia-Pacific Inhalers & Nebulizers Market
11. Europe, Middle East & Africa Inhalers & Nebulizers Market
12. Competitive Landscape
13. Competitive Portfolio
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Inhalers & Nebulizers Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Inhalers & Nebulizers Market?
3. What is the competitive strategic window for opportunities in the Inhalers & Nebulizers Market?
4. What are the technology trends and regulatory frameworks in the Inhalers & Nebulizers Market?
5. What is the market share of the leading vendors in the Inhalers & Nebulizers Market?
6. What modes and strategic moves are considered suitable for entering the Inhalers & Nebulizers Market?
Read More @ https://www.360iresearch.com/library/intelligence/inhalers-nebulizers?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhalers & Nebulizers Market worth $38.63 billion by 2030, growing at a CAGR of 22.55% - Exclusive Report by 360iResearch here
News-ID: 3428888 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Inhalers
Inhalers Market Analysis-Growth Projections
The Inhalers Market is expected to register a CAGR of 5.3% from 2025 to 2031
Download PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00021658?utm_source=OpenPR&utm_medium=10392
Market leaders and key company profiles
3M
Agilent Technologies
GlaxoSmithKline
Novartis
Propeller Health
Boehringer Ingelheim
BESPAK
AstraZeneca
Cohero Health
Segments Covered By Devices
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Nasal Inhalers
By Type
Preventive Inhalers
Reliever Inhalers
Long-Acting Bronchodilators Inhalers
By Application
Asthma
Chronic Obstructive Pulmonary Diseases
Others
By End User
Home Care
Hospitals and Clinics
Others
Contact Us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help…
Inhalers Market Size 2024 to 2031.
Market Overview and Report Coverage
The Inhalers Market refers to the pharmaceutical devices used for delivering medications directly into the lungs, thereby providing quick relief for respiratory conditions such as asthma and COPD. The market is expected to witness substantial growth over the forecasted period, with a projected CAGR of 9.30%.
Several factors are driving this growth, including the increasing prevalence of respiratory diseases worldwide, rising awareness about the…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Respiratory Inhalers Market Insights, Forecast to 2030
The report extensively examines the global Respiratory Inhalers market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Respiratory Inhalers . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market…
Smart Inhalers Market Boosting The Growth Worldwide
Precision Business Insights published a research report on “Smart Inhalers Market By Product Type (Inhalers, Metered dose inhalers, Dry powder inhalers, Nebulizers), By Application (COPD and Asthma), By Distribution channel (Hospitals, Retail pharmacies and Online pharmacies) - Global/Region/Country Forecast to 2028”.
Smart inhalers, also known as connected inhalers and sensors, are typically used as clip-on sensors on top of a normal nebulizer for the medication of COPD and asthma.…
Smart Inhaler Market - Industry Analysis, Size, Share, Growth, Trends, and Forec …
The Smart Inhaler Market is projected to gain market revenue of US$ 4,563.1 million by 2026, growing at a CAGR of 15.72% during the forecast period 2020-2026. Owing to the rising adoption of Smart Inhaler services due to the rapid increase in the aging population along with respiratory disorders associated with them. Moreover, increasing incidence of respiratory diseases, the rise in air pollution, and growth in healthcare burden owing to…
